- Home
- About Us
- Services
- Resources
- Company
CD ComputaBio's integrated ligand-based drug design service provides a powerful set of tools and analyses that enable pharmaceutical companies and research institutions to accelerate the identification and optimization of small molecule therapeutics. We offer a range of services to support drug discovery and development. With a team of skilled scientists and proven methodologies, we are dedicated to helping our clients identify potential drug leads and optimize their efficacy. Our services include pharmacodynamic modeling and virtual screening, molecular conformational analysis and quantitative structure-activity relationship (QSAR) studies.
At CD ComputaBio, we use advanced algorithms and databases to generate high-quality pharmacodynamic models based on your specific targets. Our team of experts then uses these models to perform virtual screening to identify potential lead compounds from large compound libraries.
CD ComputaBio utilizes state-of-the-art molecular dynamics (MD) simulation and computational techniques to analyze the conformational space of ligands. By exploring a wide range of conformations and their energy spectra, we can determine which conformations of a target compound are most likely to be biologically active.
QSAR plays a critical role in predicting and optimizing the activity and properties of potential drug candidates. Our CD ComputaBio team utilizes powerful computational tools to establish quantitative relationships between chemical structures and their biological activities. We employ a variety of descriptors, molecular fingerprints and machine learning algorithms to develop reliable models that help prioritize and optimize compounds.
To initiate our ligand-based drug design services, we require the following:
| Sample Requirements | Descriptions |
| Target Information | Providing us with the detailed information on the target protein/ receptor, including its structure (if available), biological function, and desired activities/inhibition. |
| Compound Library (if applicable) | Sharing the compound library you wish us to screen against the target protein. Alternatively, we can suggest and curate a diverse library tailored to your specific requirements. |
| Experimental Data (if available) | Any existing experimental data or relevant information on compounds with known bioactivities will greatly assist our computational modeling and validation processes. |
| Project Objectives | Clear definition of project goals, including the intended therapeutic area and target profiles. |
Our comprehensive ligand drug design services will provide the following:
CD ComputaBio's advanced services in ligand-based drug design represent a paradigm shift in drug discovery and development. By leveraging computational algorithms and expert analytics, we help our clients accelerate the discovery of novel therapeutics, optimize lead compounds, and make informed decisions in the quest for breakthrough treatments. Contact us today to learn more about our service information.
Reference